Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection

Microbes and Infection

Volumn 13, Issue 2, 2011, Pages 167-178

  Jha, Rajneesh ^a   Srivastava, Pragya ^a   Salhan, Sudha ^a   Finckh, Axel ^b   Gabay, Cem ^b,c   Mittal, Aruna ^a   Bas, Sylvette ^b  

^a SAFDARJUNG HOSPITAL   (India)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cervix; Chemokine receptor CCR6; Chlamydia trachomatis; Interleukin 17; Interleukin 22

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL MIGRATION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; RECEPTORS, CCR6; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS;

EID: 78651487143     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.10.012     Document Type: Article

References (47)

1. From the Centers for Disease Control and Prevention Chlamydia trachomatis genital infections-United States, 1995. JAMA 1997, 277:952-953.
2. Arno J.N., Ricker V.A., Batteiger B.E., Katz B.P., Caine V.A., Jones R.B. Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J. Infect. Dis. 1990, 162:1385-1389.
3. Reddy B.S., Rastogi S., Das B., Salhan S., Verma S., Mittal A. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses. Clin. Exp. Immunol. 2004, 137:552-558.
4. Agrawal T., Vats V., Wallace P.K., Salhan S., Mittal A. Cervical cytokine responses in women with primary or recurrent chlamydial infection. J. nterferon Cytokine Res. 2007, 27:221-226.
5. Kryczek I., Wei S., Vatan L., Escara-Wilke J., Szeliga W., Keller E.T., Zou W. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J. Immunol. 2007, 179:1423-1426.
6. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
7. Higgins S.C., Jarnicki A.G., Lavelle E.C., Mills K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 2006, 177:7980-7989.
8. Zhang X., Gao L., Lei L., Zhong Y., Dube P., Berton M.T., Arulanandam B., Zhang J., Zhong G. A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J. Immunol. 2009, 183:1291-1300.
9. Bai H., Cheng J., Gao X., Joyee A.G., Fan Y., Wang S., Jiao L., Yao Z., Yang X. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 2009, 183:5886-5895.
10. Zhou X., Chen Q., Moore J., Kolls J.K., Halperin S., Wang J. Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect. Immun. 2009, 77:5059-5070.
11. Neff L., Daher S., Muzzin P., Spenato U., Gulacar F., Gabay C., Bas S. Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein. J. Bacteriol. 2007, 189:4739-4748.
12. Bas S., Neff L., Vuillet M., Spenato U., Seya T., Matsumoto M., Gabay C. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol. 2008, 180:1158-1168.
13. Rottenberg M.E., Gigliotti-Rothfuchs A., Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 2002, 14:444-451.
14. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
15. George J.A., Panchatcharam T.S., Paramasivam R., Balasubramanian S., Chakrapani V., Murugan G. Evaluation of diagnostic efficacy of PCR methods for Chlamydia trachomatis infection in genital and urine specimens of symptomatic men and women in India. Jpn. J. Infect. Dis. 2003, 56:88-92.
16. Bas S., Muzzin P., Ninet B., Bornand J.E., Scieux C., Vischer T.L. Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J. Clin. Microbiol. 2001, 39:1368-1377.
17. Heine H., Muller-Loennies S., Brade L., Lindner B., Brade H. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur. J. Biochem. 2003, 270:440-450.
18. Prebeck S., Brade H., Kirschning C.J., da Costa C.P., Durr S., Wagner H., Miethke T. The Gram-negative bacterium Chlamydia trachomatis L2 stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin. Microbes Infect. 2003, 5:463-470.
19. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell 1994, 76:241-251.
20. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., Gery I., Lee Y.S., Egwuagu C.E. T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 2007.
21. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
22. Scriba T.J., Kalsdorf B., Abrahams D.A., Isaacs F., Hofmeister J., Black G., Hassan H.Y., Wilkinson R.J., Walzl G., Gelderbloem S.J., Mahomed H., Hussey G.D., Hanekom W.A. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 2008, 180:1962-1970.
23. Wolk K., Kunz S., Asadullah K., Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members?. J. Immunol. 2002, 168:5397-5402.
24. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., Tsujikawa T., Kitoh K., Kim-Mitsuyama S., Takayanagi A., Shimizu N., Fujiyama Y. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005, 129:969-984.
25. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
26. Misse D., Yssel H., Trabattoni D., Oblet C., Lo Caputo S., Mazzotta F., Pene J., Gonzalez J.P., Clerici M., Veas F. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J. Immunol. 2007, 178:407-415.
27. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
28. D.J. Cua, C.M. Tato, Innate IL-17-producing cells: the sentinels of the immune system, Nat. Rev. Immunol. 10 479-489.
29. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203:2271-2279.
30. + T lymphocytes. Cell Res. 2006, 16:902-907.
31. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
32. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 2007, 8:942-949.
33. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupe P., Barillot E., Soumelis V. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 2008, 9:650-657.
34. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
35. Zenewicz L.A., Flavell R.A. IL-22 and inflammation: leukin' through a glass onion. Eur. J. Immunol. 2008, 38:3265-3268.
36. Spolski R., Leonard W.J. Cytokine mediators of Th17 function. Eur. J. Immunol. 2009, 39:658-661.
37. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009, 10:864-871.
38. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10:857-863.
39. S. Eyerich, K. Eyerich, A. Cavani, C. Schmidt-Weber, IL-17 and IL-22: siblings, not twins, Trends Immunol.
40. Sallusto F., Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect. 2009, 11:620-624.
41. Fenoglio D., Poggi A., Catellani S., Battaglia F., Ferrera A., Setti M., Murdaca G., Zocchi M.R. Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 2009, 113:6611-6618.
42. Gurney A.L. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 2004, 4:669-677.
43. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., Shellito J.E., Bagby G.J., Nelson S., Charrier K., Peschon J.J., Kolls J.K. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 2001, 194:519-527.
44. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007, 8:369-377.
45. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008.
46. Liu J.Z., Pezeshki M., Raffatellu M. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine 2009, 48:156-160.
47. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., Husain S., Kreindler J.L., Dubin P.J., Pilewski J.M., Myerburg M.M., Mason C.A., Iwakura Y., Kolls J.K. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14:275-281.